Analysis of Quantum Dot Uses for Drug Delivery: Opportunities and Challenges

Introduction

One of the cutting edge fields of study concerning the engineering of atoms and molecules at the level of the nanoscale is nanotechnology. Its creation represents one of the biomedical fields’ most inventive advances in the last ten years. At the moment, the primary objective of this burgeoning subject is on creating novel kinds of nanomaterials, such as quantum dots, for multifunctional applications like gene therapy, medication delivery, and medical diagnostics. For their crucial roles in the discovery and synthesis of QDs, three scientists were awarded the 2023 Nobel Prize [1]. This recognition is due to their revolutionary studies that produced particles whose optical and electrical properties are adjusted by quantum confinement. QDs are extremely small semiconductor particles, usually with a diameter within 1-10 nanometers (nm) range. QDs typically comprise of a semiconductor-based core and a shell constructed of a different material that acts as a surface passivation layer. They have unique optical and electrical properties because to their small size, which makes them very desired for a variety of purposes [2, 3, 4]. Notably, during manufacturing, the size and shape of quantum dots may be carefully controlled, allowing for more flexibility and diversity in biological applications. For example, the optical and electrical properties of spherical QDs are different from those of cubic, rectangular, ellipsoidal, cylindrical, rod- or disk-shaped QDs. QDs are characterized by their core for electrical and optical properties, and by their shell for stability and interactions with their environment. The electrical and optical characteristics needed for a particular application are determined by the structure of the QDs. It is anticipated that the wide range of real-time biological applications of QDs would be highly beneficial in numerous research fields, including cancer dissemination, the formation of embryos leukocyte immunity, and cell-based therapies. In the near future, it is expected that postoperative tumor identification utilizing a technique called fluorescence spectroscopy may employ quantum dots as the inorganic fluorophore.

The size-dependent band gap energy is one of the main distinctions between bulk materials and QDs [5]. The band gap energy in bulk materials is a fixed characteristic that remains constant regardless its size. Secondly, the QDs band gap energy as depicted in Figure 1 is inversely related to QD size. Because it controls the quantum confinement effect’s strength, the size of the QDs is significant. Compared to bigger QDs, smaller ones have higher energy levels and stronger quantum confinement. A key element in the development of novel devices and their uses is controlling the size of the QD during growth [6]. Numerous optical characteristics are produced by this size-dependent band gap energy, such as adjustable emission and absorption spectra.

Click to enlarge

Conclusion

To summarize, QDs have the potential to be used in drug delivery applications because of their versatility, controlled release, scanning abilities, and precise administration. To reach their full potential in clinical settings, though, issues with biocompatibility, scalability, and regulatory approval must be resolved. In order to triumph over these obstacles and get QD-based medication delivery closer to clinical translation, additional research and development work is required.